2015
Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention
Rezapour T, DeVito EE, Sofuoglu M, Ekhtiari H. Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention. Progress In Brain Research 2015, 224: 345-369. PMID: 26822366, DOI: 10.1016/bs.pbr.2015.07.022.Peer-Reviewed Original ResearchMeSH KeywordsBehavior, AddictiveCognition DisordersCognitive Behavioral TherapyHumansSecondary PreventionConceptsNeurocognitive rehabilitationNeurocognitive deficitsCognitive neuroscienceDrug addictionAddiction treatmentLong-term abstinenceExecutive controlCognitive rehabilitationSustained attentionFlexible delivery methodsCognitive improvementAddictive behaviorsCognitive functionAddiction medicineNeurocognitive functionAddictive disordersEarly abstinencePsychosocial therapySustained abstinenceAbstinenceAddictionNeuroscienceDeficitsTreatment adherenceDrug useA CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans
Jensen KP, DeVito EE, Herman AI, Valentine GW, Gelernter J, Sofuoglu M. A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans. Neuropsychopharmacology 2015, 40: 2813-2821. PMID: 25948103, PMCID: PMC4864657, DOI: 10.1038/npp.2015.131.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlood PressureCognition DisordersCotinineFemaleGenome-Wide Association StudyHeart RateHumansMaleMiddle AgedNerve Tissue ProteinsNeuropsychological TestsNicotineNicotinic AgonistsPolymorphism, Single NucleotideReceptors, NicotinicSmokingSubstance Withdrawal SyndromeSurveys and QuestionnairesConceptsAversive effectsHeavy smokingRisk allelesSmoking-related disordersAfrican American smokersCHRNA5-CHRNA3Doses of nicotineHigh nicotine doseNicotine administrationIntravenous doseNicotine effectsNicotine doseAmerican smokersWithdrawal severityOvernight abstinenceAcute responseAA subjectsCardiovascular reactivityCHRNB4 gene clusterNicotineEuropean AmericansAversive responsesAdministration sessionsSmokingCognitive performance
2012
Cognitive enhancement as a treatment for drug addictions
Sofuoglu M, DeVito EE, Waters AJ, Carroll KM. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 2012, 64: 452-463. PMID: 22735770, PMCID: PMC3445733, DOI: 10.1016/j.neuropharm.2012.06.021.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBehavior TherapyCognitionCognition DisordersCombined Modality TherapyExecutive FunctionHumansNootropic AgentsSubstance-Related DisordersConceptsCognitive enhancementBehavioral interventionsExecutive inhibitory controlCognitive impairmentDrug addictionSelective cognitive functionsCurrent illicit drug usersPoor treatment retentionCognitive enhancing agentsSignificant cognitive impairmentSpecific behavioral interventionsChronic drug useCognitive remediationInhibitory controlMarijuana addictionCognitive enhancersBehavioral treatmentCognitive functionDrug use behaviorsMultiple addictionsSubstance usersTreatment retentionInhibition functionFuture researchUse behaviors
2005
The neuropsychology of normal pressure hydrocephalus (NPH)
Devito EE, Pickard JD, Salmond CH, Iddon JL, Loveday C, Sahakian BJ. The neuropsychology of normal pressure hydrocephalus (NPH). British Journal Of Neurosurgery 2005, 19: 217-224. PMID: 16455521, DOI: 10.1080/02688690500201838.Peer-Reviewed Original Research